AllCells

Advance your cell and gene therapy program with high-quality human cellular starting materials and integrated analytics – all in one place.

[AllCells @allcells_bio]

Granulocyte contamination is a key challenge in CAR-T therapy, affecting T cell expansion and therapeutic efficacy. Learn how donor selection and optimized leukapheresis protocols can improve leukopak quality and reduce granulocyte contamination: https://t.co/h8wMveeMy6

[AllCells @allcells_bio]

The recording of our LinkedIn Live “Overcoming the Challenges of Allogeneic PBMC Isolation in GMP Manufacturing Workflow” is now available. Watch the replay here: https://t.co/jRrN7XewCS

To learn more about GMP Cryopreserved PBMCs, visit our website: https://t.co/dplJPOugFk

[AllCells @allcells_bio]

Join us today for an insightful LinkedIn Live session with Dr. Yuki Kato Maves who will present a real-world case study highlighting how we partnered with a CGT developer to optimize the isolation workflow of GMP PBMCs.
https://t.co/V4w7g8Ki2b

See you at 3pm ET / 12pm PT!

[AllCells @allcells_bio]

How did Discovery’s initiative with a CGT developer significantly reduce the risk of failure and CDMO costs?

Tune into our upcoming LinkedIn Live event on 11/13, to see our real-world case study.

Register now: https://t.co/V4w7g8Ki2b

[AllCells @allcells_bio]

Attend the 6th TIL Therapies Summit at the Colonnade Hotel in Boston next week? Schedule a meeting with us to learn more about how AllCells RUO and GMP products can help advance the tumor-infiltrating lymphocyte therapy development.

Schedule a Meeting: https://t.co/A5pnh9y2VD

[AllCells @allcells_bio]

We're excited to partner with ScaleReady in the inaugural G-Rex® grant program—a $20M initiative aimed at advancing CGT development and manufacturing.  G-Rex® grant recipients gain access to exclusive offers on AllCells® RUO and GMP products.
Learn more: https://t.co/PlIkLWFOwV

[AllCells @allcells_bio]

Join our CGT team at Booth 38 during the 9th Annual CAR-TCR Summit. Our team is excited to be back in Boston from September 18-19 at the Hynes Convention Center.

Schedule a meeting:  https://t.co/9hTdZCZO10

We look forward to seeing you!

#CARTCR #immunotherapy #celltherapy

[AllCells @allcells_bio]

Unlock 20% off AllCells® Cryopreserved Cord Blood CD34+ Cells with promo code 20OFFCB.

Reserve your vials today: https://t.co/LH8Ygjt9R2

[AllCells @allcells_bio]

A clinical trial shows 3 autoimmune patients responding positively to an allogeneic CD19 CAR-T therapy—the first clinical proof-of-concept for "off the shelf" cell therapy for autoimmune diseases. Read more: https://t.co/1nUgkMqkAF
#CARTCellTherapy #AutoimmuneDiseases #Allogeneic

[AllCells @allcells_bio]

Discovery is the only CGT starting materials provider offering both volume-based and cell-count-based RUO leukopaks, enabling CGT developers to choose the best option for their specific project needs, timelines, and budgets—without compromising on quality. https://t.co/b2tlI0e3Rf

[AllCells @allcells_bio]

Get 20% off on AllCells® Matched Immune Cell Subsets with promo code “Match 20”. Use these matched samples to overcome cell source variability and achieve reliable experimental results today: https://t.co/QQLJ5ccZvj

[AllCells @allcells_bio]

In case you missed it! AllCells experts discussed real-world client cases to demonstrate how our unique donor management approach achieves high collection deliverability for various complex CGT projects.

Watch the on-demand recording now: https://t.co/WJ7PtaqBQu

[AllCells @allcells_bio]

Join our panel of AllCells experts for a LinkedIn Live event to learn how our donor management approach achieves an average 98% collection deliverability for complex cell and gene therapy (CGT) projects.

Register today: https://t.co/T7eMraFuTs

[AllCells @allcells_bio]

Our new donor management case studies are now available! Unlock valuable insights into AllCells’ unique donor ecosystem and explore real-world success stories here: https://t.co/tX2E4F2e8S

#cellandgenetherapy

[AllCells @allcells_bio]

Advance your stem cell research with our limited time offer on Cord Blood CD34+ Cells isolated from a single umbilical cord. Get 20% off list price with promo code 20OFFCB: https://t.co/U2DEu1v779

#CellTherapy #GeneTherapy #CellandGeneTherapy #Immunotherapies #AllCells #DLS

[AllCells @allcells_bio]

Dive into the data and discover why AllCells is the industry choice for mobilized apheresis collections.

Download our new mobilized leukopak technical note here: https://t.co/7qOTPTbCsw

#CellTherapy #Immunotherapies #AllCells #DLS

[AllCells @allcells_bio]

Bulk-isolate CD34+ HSPCs from single-donor mobilized leukopaks and create a reliable, quality-controlled cell bank with >90% CD34+ purity guaranteed.

Speak with us today: https://t.co/DaqQLEwRH0

#celltherapymanufacturing #celltherapy #genetherapy #DLS #AllCells

[AllCells @allcells_bio]

Get mobilized with AllCells!  High CD34+ HSPC yield in just 3 weeks with standard donor attributes. Select from four off-the-shelf regimens or collaborate with our experts for custom donor attributes.

See if you qualify for a limited-time special offer:
https://t.co/DaqQLEwRH0

[AllCells @allcells_bio]

Hurry! AllCells’ Year-End Special Event is ending soon. Save big on cryopreserved leukopaks, isolated cells, and more to help wrap up year-end projects and kickstart 2024. Act fast, supplies are limited! https://t.co/DElmPje7th

[AllCells @allcells_bio]

Dr. Yuki Kato Maves, AllCells’ Associate Director of Product Management, recently spoke at the CARTCR Summit and discussed how healthy donor materials catalyze market approval and drive sustainable manufacturing of allogeneic CGTs. Watch it on-demand: https://t.co/kNDU90BxcY